Skip to main content
SpringerLink
Log in

Antimyosin-Myokard-SPECT

  • Chapter
Book cover Single-Photon-Emissions-Computertomographie (SPECT) des Herzens

  • 42 Accesses

Zusammenfassung

Myosin ist ein ausschließlich intrazellulär vorhandenes Protein. Aufgrund seines hohen Molekulargewichtes und der niedrigen Plasmalöslichkeit wird es auch nach dem Zelltod nicht in den Kreislauf aufgenommen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Troch M, Versee L, Claeys R et al. (1993) 111In-antimyosin immunoscintigraphy as diagnostic aid in uncertain acute heart infarction. Tijdschr Geneeskd (in Dutch) 49: 1387–1390.

    Google Scholar 

  2. Budihna NV, Micinski M, Latific-Jasnic, Cerar A (1992) Indium-111-antimyosin uptake in acute and remote moycardial infarction: Comparison with pathohistologic findings. J Nucl Med 33: 587–589.

    PubMed  CAS  Google Scholar 

  3. Hendel RC, McSherry BA, Leppo JA (1990) Myocardial uptake of indium-111-labeled antimyosin in acute subendocardial infarction: Clinical, histochemical and autoradiographic correlation of myocardial necrosis. J Nucl Med 31: 1851–1853.

    PubMed  CAS  Google Scholar 

  4. Jain D, Crawley JC, Lahiri A, Raftery EB (1990) Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction. J Nucl Med 31: 231–233.

    PubMed  CAS  Google Scholar 

  5. Cortadellas Ángel J, Candell Riera J, Castell Conosa J et al. (1993) The detection of acute myocardial infarct without a Q wave; indium-111-labelled antimyosin antibodies versus techne-tium-99m-labelled radiophosphates. Rev Esp Cardiol 46: 152–159.

    PubMed  Google Scholar 

  6. Ficola U, Bonetti MG, Varrasso A et al. (1987) Indium-111-labelled antimyosin-specifìc antibodies in the diagnosis of non-q wave myocardial infarction. Nuklearmedizin 26: 165–166.

    Google Scholar 

  7. Rautio P, Vainio P, Kuikka JT et al. (1988) Indium-111 antimyosin single photon emission computed tomography and blood pool subtraction in acute non-Q-wave myocardial infarctions. Eur Heart J 9 (Suppl 1): 363 (Abstract).

    Google Scholar 

  8. Cox PH, Schonfeld D, Remme WF, Pillory M, Brons R (1987) A comparative study of myocardial infarct detection using Tc99m pyrophosphate and In111-DTPA antimyosin (RnDioFab). Int J Card Imaging 2: 197–198.

    Article  PubMed  CAS  Google Scholar 

  9. Cullom SJ, Folks RD, Cooke CD, Garcia EV (1992) Optimized simultaneous SPECT acquisition of thallium-201 and indium-111-antimyosin for cardiac risk stratifications. Circulation 86 (Suppl 1): I 419.

    Google Scholar 

  10. Giannoccaro PJ, Ruddy TD, Gulenchyn KY et al. (1990) Prediction of post-infarction ischemia with combined antimyosin and thallium imaging. Circulation 82 (Suppl 3): III202.

    Google Scholar 

  11. Johnson LL, Seidin DW, Keller AM, Wall RM, Bhatia K, Bingham CO, Tresgallo ME (1990) Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk. Circulation 81: 37–45.

    Article  PubMed  CAS  Google Scholar 

  12. Johnson LL (1992) Dual isotope thallium-201 and indium-111 antimyosin antibody tomographic imaging to identify viable myocardium at further ischemic risk after myocardial infarction. J Nucl Biol Med 36 (Suppl 2): 91–96.

    PubMed  CAS  Google Scholar 

  13. van Blies B, Baas J, van Royen EA et al. (1988) Predictive value of antimyosin uptake for wall motion improvement after thrombolysis in acute myocardial infarction. Circulation 78 (pt 2): II493.

    Google Scholar 

  14. van Blies B, Baas J, Visser CA et al. (1988) Predictive value of antimyosin uptake for wall motion improvement after thrombolysis. Eur Heart J (Suppl 1): 363 (Abstract).

    Google Scholar 

  15. van Blies B, Baas J, Visser CA, van Royen E, Delemarre BJ, Bot H, Dunning AJ (1989) Predictive value of indium-111 antimyosin uptake for improvement of left ventricular wall motion after thrombolysis in acute myocardial infarction. Am J Cardiol 64: 167–171.

    Article  Google Scholar 

  16. Burchert W, Kotzerke J, Heublein B, Hundeshagen H (1989) Diagnosis of heart transplant rejection by indium-111-labelled antimyosin scintigraphy. Eur J Nucl Med 16: 503.

    Google Scholar 

  17. Crespo MG, Pulpón LA, Dominguez P, Chamorro JL, Argueso MJ, Pradas G, Garcia M, Segovia J, Figuera D (1990) Detection of human cardiac transplant rejection with indium-111 monoclonal antimyosin antibody imaging. Transplant Proc 22: 1463.

    PubMed  CAS  Google Scholar 

  18. Frist W, Yasuda T, Segali G, Khaw BA, Strauss HW, Gold H, Stinson E, Oyer P, Baldwin J, Bil-lingham M et al. (1987) Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation 76(pt 2): V81–V85.

    PubMed  CAS  Google Scholar 

  19. Ballester M, Obrador D, Carrió I, Moya C, Auge JM, Bordes R, Marti V, Bosch I, Berna-Roqueta L, Estorch M et al. (1992) Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart trans-plation (see comments). Circulation 85: 61–68.

    PubMed  CAS  Google Scholar 

  20. Latre JM, Arizón JM, Jiménez-Heffernan A, Anguita M, Gonzalez FM, Rubio FL, Mesa MD, Montero A, Valles F, Concha M (1992) Noninvasive radioisotopic diagnosis of acute heart rejection. J Heart Lung Transplant 11(pt 1): 453–457.

    PubMed  CAS  Google Scholar 

  21. Brandl U, Reichenspurner H, Schütz A, Vetter HO, Kozlik-Feldmann R, Schmoeckel M, Kirsch CM, Netz H, Reichart B (1994) Antimyosin scintigraphy after orthotopic heart transplantation in children. Transplant Proc 26: 205–206.

    PubMed  CAS  Google Scholar 

  22. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP (1996) The Registry of the International Society for Heart and Lung Transplantation: Thirteenth Official Report - 1996. J Heart Lung Transplant 15: 655–674.

    PubMed  CAS  Google Scholar 

  23. Haber E, Yasuda T, Palacios IF et al. (1987) Antimyosin antibody imaging in the diagnosis of acute myocarditis. Eur Heart J 8(Suppl J): 119–123.

    Google Scholar 

  24. Yasuda T, Palacios IF, Khaw BA et al. (1986) Monoclonal indium-111 antimyosin antibody imaging vs. right ventricular biopsy in the diagnosis of acute myocarditis. J Nucl Med 27:910.

    Google Scholar 

  25. Yasuda T, Palacios IF, Dec GW, Fallon JT, Gold HK, Leinbach RC, Strauss HW, Khaw BA, Haber E (1987) Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 76: 306–311.

    Article  PubMed  CAS  Google Scholar 

  26. Dec GW, Palacios IF, Yasuda T, Fallon JT, Khaw BA, Strauss HW, Haber E (1990) Antimyosin antibody cardiac imaging: Its role in the diagnosis of myocarditis. J Am Coll Cardiol 16: 97–104.

    Article  PubMed  CAS  Google Scholar 

  27. Carrió I, Berna L, Ballester M, Estorch M, Obrador D, Chadellas M, Abadal L, Ginjaume M (1988) Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 29: 1893–1900.

    PubMed  Google Scholar 

  28. Lekakis J, Nanas J, Moustafellou A, Kostamis P, Moulopoulos S (1993) Antimyosin scintigraphy for detection of myocarditis. Scintigraphic follow-up. Chest 104: 1427–1430.

    Article  CAS  Google Scholar 

  29. Bergler-Klein J, Sochor H, Stanek G, Globits S, Ullrich R, Glogar D (1993) Indium-111 monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis. Arch Intern Med 153: 2696–2700.

    Article  PubMed  CAS  Google Scholar 

  30. Casáns I, Villar A, Almenar V, Blanes A (1989) Lyme myocarditis diagnosed by indium-111-antimyosin antibody scintigraphy. Eur J Nucl Med 15: 330–331.

    Article  PubMed  Google Scholar 

  31. Castell J, Fraile M, Garcia A, Encabo G, Cortadellas J, Galve E, Candell J (1994) Pericardial and myocardial localization of antimyosin in case of acute myocarditis. J Nucl Med 35: 469–470.

    PubMed  CAS  Google Scholar 

  32. Le Guludec D, Weinmann P, Namade M, Lhote F, Faroggi M, Lanfranchi J, Guillein L, Moretti IL (1992) Prevalence of myocarditis in acquired immunodeficiency syndrome (AIDS): an Indium-111 antimyosin scintigraphic study. Eur J Nucl Med 19: 671 (Abstaract).

    Google Scholar 

  33. Narula J, Southern JF, Abraham S, Pieri P, Khaw BA, Yasuda T (1991) Myocarditis simulating myocardial infarction. J Nucl Med 32: 312–318.

    PubMed  CAS  Google Scholar 

  34. Narula J, Khaw BA, Dec GW Jr., Palacios IF, Southern JF, Fallon JT, Strauss HW, Haber E, Yasuda T (1993) Brief report: Recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 328: 100–104.

    Article  PubMed  CAS  Google Scholar 

  35. Lambert K, Isaac D, Hendel R (1993) Myocarditis masquerading as ischemic heart disease: the diagnostic utility of antimyosin imaging. Cardiology 82: 415–422.

    Article  PubMed  CAS  Google Scholar 

  36. Obrador D, Ballester M, Carrió I, Berna L, Pows-Llado G (1989) High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 13: 1289–1293.

    Article  PubMed  CAS  Google Scholar 

  37. Munz DL, Figulla HR, Morguet A, Bardossi A, Holt-Grieb A, Emrich D (1990) Assessment of the cardiac status in dilated cardiomyopathy (DCM) by combining histomorphometric and scintigraphic parameters. Eur J Nucl Med 16: 499.

    Google Scholar 

  38. Obrador D, Ballester M, Carrió I, Moya C, Bosch I, Marti V, Berna L, Estorch M, Udina C, Marrugat J et al. (1994) Presence, evolving changes and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies. Circulation 89: 2054–2061.

    PubMed  CAS  Google Scholar 

  39. Obrador D, Ballester M, Carrió I et al. (1989) Monoclonal antimyosin antibody studies vs. light microscopy in the detection of myocyte damage. Eur Heart J 10 (Suppl): 247 (Abstr).

    Google Scholar 

  40. Werner GS, Figulla HR, Munz DL, Klingel K, Kandolf R, Emrich D, Kreuzer H (1993) Myocardial indium-111 antimyosin uptake in patients with idiopathic dilated cardiomyopathy: Its relation to haemodynamics, histomorphometry, myocardial enteroviral infection and clinical course. Eur Heart J 14: 175–184.

    Article  PubMed  CAS  Google Scholar 

  41. Palacios I, Yasuda T, Khaw BA et al. (1986) Indium-111 antimyosin antibody imaging in the follow-up patients with acute dilated cardiomyopathy. Am Heart Assoc Monogr o: II142.

    Google Scholar 

  42. Horváth M, Pszota, Karman M, Boszormenyi E, Rakies F, Bodor M, Pal T (1990) Indium-111 human antimyosin monoclonal antibody-fragment study on alcoholic (and diabetic) cardio-myopathic patients (ACM-DCM) with Centocor Europe Myoscint (MSC). ACTA Biochemi Biophys Hung 25: 165–173.

    Google Scholar 

  43. Nakata T, Gotoh M, Yonekura S, Tanaka S, Shimamoto K, Kubota M, Tsuda T, Jimura O (1991) Myocardial accumulation of monoclonal antimyosin Fab in hypertrophic cardiomyopathy and postpartum cardiomyopathy. J Nucl Med 32: 2291–2294.

    PubMed  CAS  Google Scholar 

  44. Nishimura T, Nagata S, Uehara T, Hayashida K, Mitari I, Kumita SI (1991) Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-111-anti-myosin Fab myocardial scintigraphy. J Nucl Med 32: 1333–1337.

    PubMed  CAS  Google Scholar 

  45. Munz DL, Werner GS, Morguet AJ, Figulla HR, Kreuzer H, Emrich D (1992) Myocardial Indium-111 antimyosin Fab accumulation in patients with dilated cardiomyopathy - Prognostic impact? Eur J Nucl Med 19: 669.

    Google Scholar 

  46. Munz DL, Werner GS, Morguet AJ et al. (1993) Is there a prognostic relevance of myocardial Indium-111 antimyosin Fab accumulation in patients with dilated cardiomyopathy? J Nucl Med 34 (Suppl): 153.

    Google Scholar 

  47. Kawai C, Matsumori A, Nishimura T et al. (1990) Indium-111-labeled antimyosin Fab scintigraphy in cardiovascular diseases - Multicenter clinical trial. Jpn J Nucl Med (in Japanese) 27: 1419–1432.

    CAS  Google Scholar 

  48. Carrió I, Duncker D, Serra-Grima R, Berná L, Estorch M, Torres G (1992) Assessment of myocyte damage in pathologic cardiac hypertrophy by Indium-111 antimyosin studies. Eur J Nucl Med 19: 665.

    Google Scholar 

  49. Carrió I, Serra-Grima R, Berná L, Estorch M, Martinez-Duncker C, Ordonez J (1990) Transient alterations in cardiac performance after a six-hour race. Am J Cardiol 65: 1471–1474.

    Article  PubMed  Google Scholar 

  50. Carrió I, Serra-Grima R, Subirana M, Berná L, Estorch M, Bayés A (1995) Distinction Between Physiologic And Pathologic Myocardial Hypertrophy: Role of 111In-Antimyosin Antibody Studies. Eur J Nucl Med 22: 828 (Abstract).

    Article  Google Scholar 

  51. Carrió I, Lopez-Pousa J, Estorch M, Duncker D, Beriá L, Torres G, de Andrés L (1993) Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. J Nucl Med 34: 1503–1507.

    PubMed  Google Scholar 

  52. Cox PH, Planting A, Verweij J, Pillay M, Stoter G, Schonfeld D (1988) Indium-111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma. Eur J Nucl Med 14: 50–52.

    Article  PubMed  CAS  Google Scholar 

  53. Cox PH, Pillay M, Planting A et al. (1988) Indium-111 antimyosin for the in-vitro detection of myosarcoma. Eur J Nucl Med 14: 322.

    Article  Google Scholar 

  54. Carrió I, Lopez-Pousa J, Duncker D et al. (1993) Assessment of cardiotoxicity in patients with sarcomas by 111In-antimyosin studies: bolus administration versus continuous infusion of doxorubicin. Intl J Biol Markers 8: 258–259.

    Google Scholar 

  55. Estorch M, Carrió I, Berná L, Martinez-Duncker C, Alonso C, Ojeda B (1989) Indium-111 antimyosin myocardial uptake in patients under adriamycin therapy for advanced breast cancer. Eur J Nucl Med 15: 465 (Abstract).

    Google Scholar 

  56. Estorch M, Carrió I, Berná L, Martinez-Duncker C, Alonso C, Germa JR, Ojeda B (1990) Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. Nuklearmedizin 31: 1965–1969.

    CAS  Google Scholar 

  57. Estorch M, Carrió I, Lopez-Pousa J, Berná L, Torres G (1993) Comparison of iodine-131 MIBG and indium-111 antimyosin studies to assess cardiotoxicity during doxorubicin administration. J Nucl Med 34 (Suppl): 13–14.

    Google Scholar 

  58. Carrió I, Estorch M, Berná L, Duncker D, Torres G (1992) Early detection of patients at risk of congestive heart failure during adriamycin therapy by means of indium-111 antimyosin studies. J Nucl Med 33 (Suppl): 895.

    Google Scholar 

  59. Jain D, Zaret BL (1990) Editorial: Antimyosin cardiac imaging: Will it play a role in the detection of doxorubicin cardiotoxicity? J Nucl Med 31: 1970–1974.

    PubMed  CAS  Google Scholar 

  60. Lekakis J, Vassilopoulos N, Psichoyiou H, Athanassiadis P, Gerali S, Kostamis P, Moulopoulus S (1991) Doxorubicin cardiotoxicity detected by indium-111 myosin-specific imaging. Eur J Nucl Med 18: 225–226.

    Article  PubMed  CAS  Google Scholar 

  61. Valdés Olmos RA, ten Bokkel Huinink WE, ten Hoeve RFA, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA (1994) Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction. Ann Oncol 5: 617–622.

    PubMed  Google Scholar 

  62. Yamada T, Matsumori A, Tamaki N et al. (1991) Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging. Jpn Circ J (in Japanese) 55: 377–383.

    Article  CAS  Google Scholar 

  63. Marti V, Ballester M, Udina C, Carrio I, Alvarez E, Obrador D, Pons-Llado G (1995) Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. Circulation 91: 1619–1623.

    PubMed  CAS  Google Scholar 

  64. Dec GW (1991) Current indications for endomyocardial biopsy. Prim Cardiol 17: 34, 39–40, 42, 44–46.

    Google Scholar 

  65. Krause Th, Schümichen C, Beck A et al. (1990) Scintigraphy in a case of Churg-Strauss vasculitis with myocardial involvement using 111In-labelled antimyosin. Nuklearmedizin 29: 177–179.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. J. Wieler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Bickel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bundeswehrzentralkrankenhaus Koblenz, Rübenacher Straße 170, 56072, Koblenz, Germany

    Helmut J. Wieler (Leitender Arzt der Abt. Nuklearmendizin) (Leitender Arzt der Abt. Nuklearmendizin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin hiedelberg

About this chapter

Cite this chapter

Wieler, H.J., Bickel, C. (1997). Antimyosin-Myokard-SPECT. In: Wieler, H.J. (eds) Single-Photon-Emissions-Computertomographie (SPECT) des Herzens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60621-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60621-2_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64479-5

  • Online ISBN: 978-3-642-60621-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation